The 25th Asia-Pacific Dermatology Conference is going to be held at Osaka, Japan during October 09-10, 2019. Through the theme: “Innovative techniques against major skin diseases and defects”, the conference will explore the advances in Dermatology. This conference is mainly for practicing Dermatologist, Dermatologist in training and other healthcare professionals interested in the latest advances and techniques in the field.
Patients with bilateral anterior circulation aneurysms present a management challenge. These lesions may be treated in a staged manner or alternatively, for select patients, a contralateral approach may be utilized to treat bilateral aneurysms with a single surgery. In this narrated video illustration, the authors present the case of a 57-year-old woman with incidentally discovered bilateral aneurysms (left middle cerebral artery (MCA), left anterior choroidal artery and right MCA). A contralateral approach through a left pterional craniotomy was performed for microsurgical clipping of all three aneurysms. The techniques of pterional craniotomy, contralateral approach, microsurgical clipping, and intraoperative angiography are reviewed.
UCLA urologist- Dr. Robert Reiter, MD, gives an overview of genomic testing options to evaluate the genetic make-up of the tumor and predict the aggressiveness of your prostate cancer.
Dr. Mohammad Jahanzeb, MD, professor of clinical medicine, Hematology/Oncology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, discusses immunotherapy in the treatment of elderly patients with non–small cell lung cancer.
6th International conference on Rhinology and Otology is going to be held during September 13-14, 2019, Singapore which includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions. The theme of the conference “Briefing the medical revolution in the field of Rhinology and Otology”. The two days of educational program will include keynote presentations, session speakers, and poster presenters on the latest in innovative techniques as well as papers in the areas of Otorhinolaryngology conferences, Otolaryngology conferences, ENT conferences, workshops on Rhinology, conferences on Otology, Laryngology, Head and Neck Surgery, Facial Plastics, Sleep - in adults & pediatrics and Oral Health.
“Global Experts Meeting on Pulmonology and Respiratory Medicine” is going to be conducted in the city of London, UK on November 18-19, 2019. This extraordinary conference revolves around the theme “Innovative Study on Pulmonology & Neoteric developments in Respiratory Research”. It is a common platform designed for International medical health professionals and pulmonologists to facilitate the dissemination and application of research findings related to the Lungs. The Pulmonology conference provides a global forum for discussions about new innovations to International scientists, researchers, doctors, young students as well as business professionals related to pulmonology.
9th World Congress on Breast Cancer Conference is going to held during April 25-26, 2019 at London, the UK with a theme ‘’Determining the possible ways to cure and prevent breast cancer’’. It aims to bring together the Professors, Researchers, scientists, business giants and technocrats to provide an international forum for the dissemination of original research results, new ideas, and practical development and discover advances in health practice, management, and education in relation to health disparities as well as a breadth of other topics.
Osteo-Arthritis complications 2019 which is scheduled during October 24-25, 2019, at Frankfurt, Germany. The main theme of our conference is “Therapeutic approaches for prevention of Osteo Complications" which covers a wide range of critically important sessions. It’s a platform to bring all the Neurologists & orthopedic surgeons together to share their experiences it’s the amalgam of scientific research as well as innovative ideas.
This is an open-label, multi-dose, single-arm, multi-center, Phase 1, dose-escalation study to define a maximum tolerated dose and schedule (MTDS), describe preliminarily safety, and to assess PK, immunogenicity, immunomodulatory activity, and potential anti-tumor activity of MGD006 in patients with AML or MDS whose disease is not expected to benefit from cytotoxic chemotherapy. The primary goal of this Phase 1, dose-escalation study, is to determine the maximum tolerated dose level of MGD006 in patients with AML and MDS whose disease is not expected to benefit from cytotoxic chemotherapy.
This clinical study is researching a new technology to treat a specific type of knee cartilage injuries. The study is comparing their product and technique to a standardized and regularly performed procedure. Patients who qualify for this trial will receive all study related medication and care at no cost to them or their insurance company. The study is covering the entire cost of surgery for patients who qualify.